Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-056660

Director sold 10,000 shares at $6.44 ($64,361)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2015-09-24 Option exercise +10,000 $0.88 $8,750 65,746 D: show line 1 in the form
Kraus Al Director 2015-09-24 Sale −10,000 $6.44 $64,361 55,746 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $6.44 · $64,361

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kraus Al Director 2015-09-24 Option exercise · Stock Option −10,000 36,773 D: show line 3 in the form
Loading xslF345X03/v420993_4.xml…